[Next-Generation Sequencing Book]
  • [Photo] J.W. Bizzaro • March 9, 2000
    "A newly issued patent on a gene that controls how AIDS begins infecting its victims is fueling controversy over who should own and profit from the torrent of genetic discoveries emerging from research labs and biotech companies across the country. The patent, issued earlier this month to Maryland-based Human Genome Sciences, gives the company sweeping control over who gets to use the gene in commercial development of a new class of AIDS drugs, even though the firm knew nothing of the gene's role in AIDS when it sought the patent....But the academic scientists who discovered the gene's role in AIDS, as well as AIDS activists and some legal scholars, argue that the decision is a case of the patent system gone awry. They charge that the patent and thousands of other gene patents likely to be granted shortly will slow, not speed, the development of new drugs and entangle basic research for years to come."

    Full story: http://www.latimes.com/news/nation/updates/lat_gene000228.htm

    Can I get an amen, brothers? Amen! Link by Snowdeal.org.

Discussion forums: LA Times: Experts Fret Over Effect of Gene Patents

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.